Discover why AI-driven pharmacovigilance is no longer optional. Learn how AI automates case intake, enhances signal detection, and enables real-time benefit–risk decisions to keep pace with complex drug safety demands and regulatory expectations.
Discover how AI and machine learning are transforming small molecule drug discovery—from generative models and property prediction at scale to on-demand molecule design that compresses R&D timelines from years to months.
Learn what zavegepant is, how this intranasal CGRP receptor antagonist works for acute migraine treatment, and why its non‑vasoconstrictive, needle‑free nasal spray delivery may benefit patients with nausea or cardiovascular risk factors.
Learn what tirzepatide is, how its dual GIP and GLP‑1 receptor agonism works, and why it delivers bariatric surgery–level weight loss and powerful metabolic benefits in obesity and type 2 diabetes.
Learn how to move beyond AI pilots in pharmacovigilance and design AI-ready drug safety workflows. Explore end-to-end safety pipelines for case intake, triage, signal detection, and decision support that are compliant, scalable, and deliver real-world impact.
Learn what deucravacitinib is, how its selective TYK2 allosteric inhibition works, and why it’s reshaping treatment for moderate‑to‑severe plaque psoriasis with biologic‑like efficacy and a differentiated safety profile.
Learn how PROTAC small molecules are redefining cancer therapy by harnessing targeted protein degradation to eliminate “undruggable” oncogenic drivers, overcome resistance, and expand the frontier of small molecule oncology.
Discover how CRISPR–Cas9 is evolving from a genome-editing lab tool into a programmable protein drug. Explore viral vectors, lipid nanoparticles, and peptide-based delivery strategies that enable safe, one‑time gene editing therapies for diseases like sickle cell and inherited retinal disorders.
Learn how AI-powered pharmacovigilance transforms drug safety from manual, reactive case processing to real-time, data-driven surveillance using NLP, machine learning, and intelligent automation—while maintaining scientific rigor and regulatory compliance.
Discover how AI-powered digital safety twins are reshaping pharmacovigilance by turning static safety profiles into real-time, learning risk models. Learn how virtual replicas of drugs, patients, and treatment pathways enable proactive risk prediction, dynamic stratification, and scenario simulation across the product lifecycle.